UK MIDDAY BRIEFING: House Builders Soar As BOE Stays Calm
26th Jun 2014 13:19
LONDON (Alliance News) - Pharmaceutical company AstraZeneca PLC Wednesday said Chief Financial Officer Marc Dunoyer was awarded 4,824 shares under a company share plan at 4,385 pence per share, as the first tranche of awards vested Monday. The company also said Briggs Morrison, a divisiona Read More
(An item published at 0717 BST misspelled the name Movantik. The correct version follows.) LONDON (Alliance News) - AstraZeneca PLC said late Thursday the US Food and Drug Administration's Analgesic Drug Products Advisory Committee has recommended the FDA not require cardiovascular outcomes Read More
LONDON (Alliance News) - UK residential and commercial property companies are among the biggest fallers in a declining market Friday, after Bank of England Governor Mark Carney said the interest rates in the UK could rise sooner than investors expect and Chancellor of the Exchequer George Osbo Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Petra Diamonds</strong> Ltd shares jumped to the top of the FTSE 250 index after saying it has recovered another exceptional 122.52 carat Read More
LONDON (Alliance News) - The deteriorating situation in Iraq has depressed shares early Friday, as the UK market also contemplates a sooner-than-expected rise in interest rates by the Bank of England.<br /><br /><strong>SSE</strong>,<strong> Tullow Oil</strong> and <strong>BG Group</strong> le Read More
LONDON (Alliance News) - AstraZeneca PLC said late Thursday the US Food and Drug Administration's Analgesic Drug Products Advisory Committee has recommended the FDA not require cardiovascular outcomes trials for a class of drugs including AstraZeneca's movantix treatment. Movantix is a mu-o Read More
LONDON (Alliance News) - The FTSE 100 closed fractionally higher Thursday, having spent the day trading within a tight range, with oil and gas exploration and production company <strong>BG Group</strong> leading the gains as the price of oil climbed amid escalating violence in Iraq.<br /><br / Read More
LONDON (Alliance News) - <strong>Lonmin</strong> Thursday said it has reached a tentative deal over wages and working conditions with the leadership of the union that has brought the South African platinum mining industry to a halt for several months.<br /><br />In a statement, the company sai Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>ITV</strong>, up 2.7%. ITV's shares have spent June trading in tight ranges, and Libe Read More
LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />The initial public offering of <strong>B&M European Value Retail</strong> SA, the discount retailer chaired by former<strong> Tesco</strong Read More
LONDON (Alliance News) - UK shares have opened flat Thursday, following negative trading in the US and Asia overnight. <br /><br /><strong>AstraZeneca</strong> is the third biggest gainer on the FTSE 100. The drugmaker said it has signed a global licence agreement with AIM-listed biotechnology Read More
LONDON (Alliance News) - AstraZeneca PLC said Thursday that it had signed a global licence agreement with AIM-listed biotechnology company Synairgen PLC for its SNG001 compound for the treatment of infections that exacerbate asthma. The compound is used to treat respiratory tract infections Read More
LONDON (Alliance News) - AstraZeneca PLC and Amgen Inc said late Wednesday that phase II study results of psoriatic arthritis drug brodalumab showed that the treatment showed significant improvement in clinical symptoms. The results, which were published in the New England Journal of Medici Read More
LONDON (Alliance News) - <strong>J Sainsbury</strong> Wednesday reported another drop in like-for-like sales, its second consecutive quarterly decline after nine years of unbroken sales growth. <br /><br />The UK's third-largest supermarket chain by market share posted a 1.1% decline in like-f Read More